Developing New Drugs for Diabetes and Cardiometabolic Disorders Andrew J. KrentzLinda MorrowMarcus Hompesch Editorial 06 January 2012 Pages: 1709 - 1711
Will Abuse-Deterrent Formulations of Opioid Analgesics Be Successful in Achieving Their Purpose? Bernard Bannwarth Current Opinion 06 January 2012 Pages: 1713 - 1723
Polymorphisms of Estrogen Receptors and Risk of Depression Joanne RyanMarie-Laure Ancelin Leading Article 06 January 2013 Pages: 1725 - 1738
New Oral Anticoagulants Birgitte Klindt PoulsenErik Lerkevang GroveSteen Elkjaer Husted Review Article 06 January 2012 Pages: 1739 - 1753
Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients Ida Ehlers AlbertsenTorben Bjerregaard LarsenGregory Y. H. Lip Systematic Review 06 January 2012 Pages: 1755 - 1764
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) Paul L. McCormack Adis Drug Evaluation 06 January 2012 Pages: 1765 - 1791